Clinical Trial 55554

New York, NY 10065


Researchers at The Rockefeller University are testing the safety of a new investigational antibody against chronic hepatitis B. Hepatitis B virus (HBV) remains a major global health problem with an estimated 257 million people living with the infection worldwide. HBV medications can reduce HBV to very low levels in the blood and parHally repair the immune system (the system that helps your body respond to diseases).

The purpose of this research study is to evaluate the safety and tolerability of intravenous (through a vein in your arm) infusions of a new drug.

You may be eligible if you:

Are between the ages of 18 and 70

Have a chronic hepatitis B infetion and are currently on antiviral treatment

Do not have HIV or hepatitis C

Qualified Participants May Receive:

Participation includes:

A screening visit at the RU Hospital for blood work, urine sample and to complete consent forms

Infusions of the antibody

Follow-up visits up to 48 weeks.

Compensation is provided

Available At:

Rockefeller University Hospital
1230 York Avenue
New York, NY 10065
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.